S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
Log in
LON:GSK

GlaxoSmithKline plc (GSK.L) Share Forecast, Price & News

GBX 1,385.60
-24.20 (-1.72 %)
(As of 01/28/2021 08:51 AM ET)
Add
Compare
Today's Range
1,383
Now: GBX 1,385.60
1,399.60
50-Day Range
1,330.13
MA: GBX 1,378.04
1,418.94
52-Week Range
1,284
Now: GBX 1,385.60
1,847
Volume607,594 shs
Average Volume7.44 million shs
Market Capitalization£69.70 billion
P/E Ratio10.97
Dividend Yield5.51%
BetaN/A
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
GlaxoSmithKline plc (GSK.L) logo

MarketRank

Overall MarketRank

2.09 out of 5 stars

Analyst Opinion: 3.1Community Rank: 1.9Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-80475000
Employees99,437
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£34.26 billion
Cash FlowGBX 87.40 per share
Book ValueGBX 286.90 per share

Profitability

Miscellaneous

Outstanding Shares5,029,980,160
Market Cap£69.70 billion
Next Earnings Date2/3/2021 (Estimated)
OptionableOptionable
GBX 1,385.60
-24.20 (-1.72 %)
(As of 01/28/2021 08:51 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GSK News and Ratings via Email

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











GlaxoSmithKline plc (GSK.L) (LON:GSK) Frequently Asked Questions

How has GlaxoSmithKline plc (GSK.L)'s stock been impacted by COVID-19 (Coronavirus)?

GlaxoSmithKline plc (GSK.L)'s stock was trading at GBX 1,522.60 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, GSK shares have decreased by 8.0% and is now trading at GBX 1,400.80.
View which stocks have been most impacted by COVID-19
.

Is GlaxoSmithKline plc (GSK.L) a buy right now?

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline plc (GSK.L) in the last twelve months. There are currently 2 sell ratings, 10 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" GlaxoSmithKline plc (GSK.L) stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GSK, but not buy additional shares or sell existing shares.
View analyst ratings for GlaxoSmithKline plc (GSK.L)
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than GlaxoSmithKline plc (GSK.L)?

Wall Street analysts have given GlaxoSmithKline plc (GSK.L) a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but GlaxoSmithKline plc (GSK.L) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is GlaxoSmithKline plc (GSK.L)'s next earnings date?

GlaxoSmithKline plc (GSK.L) is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021.
View our earnings forecast for GlaxoSmithKline plc (GSK.L)
.

How were GlaxoSmithKline plc (GSK.L)'s earnings last quarter?

GlaxoSmithKline plc (GSK.L) (LON:GSK) announced its quarterly earnings data on Wednesday, July, 29th. The company reported $56.90 earnings per share for the quarter.
View GlaxoSmithKline plc (GSK.L)'s earnings history
.

How often does GlaxoSmithKline plc (GSK.L) pay dividends? What is the dividend yield for GlaxoSmithKline plc (GSK.L)?

GlaxoSmithKline plc (GSK.L) declared a dividend on Wednesday, October 28th. Stockholders of record on Thursday, November 12th will be given a dividend of GBX 19 per share on Thursday, January 14th. This represents a dividend yield of 1.44%. The ex-dividend date of this dividend is Thursday, November 12th. The official announcement can be accessed at this link.
View GlaxoSmithKline plc (GSK.L)'s dividend history
.

Is GlaxoSmithKline plc (GSK.L) a good dividend stock?

GlaxoSmithKline plc (GSK.L) pays an annual dividend of GBX 76 per share and currently has a dividend yield of 5.51%. GSK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of GlaxoSmithKline plc (GSK.L) is 60.17%. This payout ratio is at a healthy, sustainable level, below 75%.
View GlaxoSmithKline plc (GSK.L)'s dividend history.

What price target have analysts set for GSK?

19 brokerages have issued twelve-month target prices for GlaxoSmithKline plc (GSK.L)'s shares. Their forecasts range from GBX 1,300 to GBX 2,240. On average, they anticipate GlaxoSmithKline plc (GSK.L)'s share price to reach GBX 1,732.38 in the next twelve months. This suggests a possible upside of 23.7% from the stock's current price.
View analysts' price targets for GlaxoSmithKline plc (GSK.L)
or view Wall Street analyst' top-rated stocks.

Who are some of GlaxoSmithKline plc (GSK.L)'s key competitors?

What other stocks do shareholders of GlaxoSmithKline plc (GSK.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GlaxoSmithKline plc (GSK.L) investors own include AstraZeneca PLC (AZN.L) (AZN), General Electric (GE), Royal Dutch Shell plc (RDSB.L) (RDSB), Vodafone Group Plc (VOD.L) (VOD), Intel (INTC), NVIDIA (NVDA), Johnson & Johnson (JNJ), AT&T (T), Barclays PLC (BARC.L) (BARC) and Gilead Sciences (GILD).

Who are GlaxoSmithKline plc (GSK.L)'s key executives?

GlaxoSmithKline plc (GSK.L)'s management team includes the following people:
  • Ms. Emma N. Walmsley, CEO & Director (Age 50, Pay $3.29M)
  • Mr. Iain James Mackay, CFO & Exec. Director (Age 58, Pay $2.36M)
  • Dr. Hal V. Barron, Chief Scientific Officer, Pres of R&D and Director (Age 57, Pay $6.34M)
  • Ms. Karenann K. Terrell, Chief Digital & Technology Officer (Age 59)
  • Ms. Sarah Elton-Farr, Head of Investor Relations
  • Mr. Nick Hirons, Sr. VP of Global Ethics & Compliance
  • Mr. James Ford, Sr. VP & Gen. Counsel
  • Ms. Sally Jackson, Sr. VP of Global Communications & CEO Office
  • Ms. Diana Conrad, Sr. VP of HR
  • Mr. David Simon Redfern, Chief Strategy Officer (Age 54)

What is GlaxoSmithKline plc (GSK.L)'s stock symbol?

GlaxoSmithKline plc (GSK.L) trades on the London Stock Exchange (LON) under the ticker symbol "GSK."

How do I buy shares of GlaxoSmithKline plc (GSK.L)?

Shares of GSK and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is GlaxoSmithKline plc (GSK.L)'s stock price today?

One share of GSK stock can currently be purchased for approximately GBX 1,400.80.

How big of a company is GlaxoSmithKline plc (GSK.L)?

GlaxoSmithKline plc (GSK.L) has a market capitalization of £70.46 billion and generates £34.26 billion in revenue each year. GlaxoSmithKline plc (GSK.L) employs 99,437 workers across the globe.

What is GlaxoSmithKline plc (GSK.L)'s official website?

The official website for GlaxoSmithKline plc (GSK.L) is www.gsk.com.

How can I contact GlaxoSmithKline plc (GSK.L)?

GlaxoSmithKline plc (GSK.L)'s mailing address is 980 Great West Road, BRENTFORD, TW8 9GS, United Kingdom. The company can be reached via phone at +44-20-80475000.

This page was last updated on 1/28/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.